{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:35:06Z","timestamp":1791434106161,"version":"4.3.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00464-023-10649-y","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T19:02:10Z","timestamp":1706122930000},"page":"1131-1138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal\/pelvic cancer-related surgery: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-5064","authenticated-orcid":false,"given":"Hong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"issue":"11","key":"10649_CR1","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1245\/s10434-018-6671-7","volume":"25","author":"PE Serrano","year":"2018","unstructured":"Serrano PE, Parpia S, Linkins LA, Elit L, Simunovic M, Ruo L, Bhandari M, Levine M (2018) Venous thromboembolic events following major pelvic and abdominal surgeries for cancer: a prospective cohort study. Ann Surg Oncol 25(11):3214\u20133221. https:\/\/doi.org\/10.1245\/s10434-018-6671-7","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10649_CR2","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","volume":"23","author":"D Farge","year":"2022","unstructured":"Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Mu\u00f1oz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-Garc\u00eda LA, Bounameaux H, Pabinger I, Douketis J (2022) 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol 23(7):e334\u2013e347. https:\/\/doi.org\/10.1016\/S1470-2045(22)00160-7","journal-title":"Lancet Oncol"},{"issue":"4","key":"10649_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, Leavitt AD, Lee AYY, Macbeth F, Morgan RL, Noble S, Sexton EA, Stenehjem D, Wiercioch W, Kahale LA, Alonso-Coello P (2021) American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5(4):927\u2013974. https:\/\/doi.org\/10.1182\/bloodadvances.2020003442","journal-title":"Blood Adv"},{"issue":"5","key":"10649_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"34","author":"A Falanga","year":"2023","unstructured":"Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, Lecumberri R, Mandala M, Maraveyas A, Pabinger I, Sinn M, Syrigos K, Young A, Jordan K (2023) Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol 34(5):452\u2013467. https:\/\/doi.org\/10.1016\/j.annonc.2022.12.014","journal-title":"Ann Oncol"},{"issue":"8","key":"10649_CR5","doi-asserted-by":"publisher","first-page":"Cd004318","DOI":"10.1002\/14651858.CD004318.pub5","volume":"8","author":"S Felder","year":"2019","unstructured":"Felder S, Rasmussen MS, King R, Sklow B, Kwaan M, Madoff R, Jensen C (2019) Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 8(8):Cd004318. https:\/\/doi.org\/10.1002\/14651858.CD004318.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"10649_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.thromres.2021.06.010","volume":"204","author":"W Knoll","year":"2021","unstructured":"Knoll W, Fergusson N, Ivankovic V, Wang T-F, Caiano L, Auer R, Carrier M (2021) Extended thromboprophylaxis following major abdominal\/pelvic cancer-related surgery: a systematic review and meta-analysis of the literature. Thrombosis Res 204:114\u2013122. https:\/\/doi.org\/10.1016\/j.thromres.2021.06.010","journal-title":"Thrombosis Res"},{"issue":"3","key":"10649_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ygyno.2020.06.505","volume":"158","author":"ME Ross","year":"2020","unstructured":"Ross ME, Glickman A, Brennecke A, Tayebnejad A, Guntupalli SR (2020) Adherence to postoperative thromboprophylactic medication among gynecologic oncology patients: a subanalysis. Gynecol Oncol 158(3):754\u2013759. https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.505","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10649_CR8","doi-asserted-by":"publisher","first-page":"e207410","DOI":"10.1001\/jamanetworkopen.2020.7410","volume":"3","author":"SR Guntupalli","year":"2020","unstructured":"Guntupalli SR, Brennecke A, Behbakht K, Tayebnejad A, Breed CA, Babayan LM, Cheng G, Ramzan AA, Wheeler LJ, Corr BR et al (2020) Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial. JAMA Network Open 3(6):e207410. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.7410","journal-title":"JAMA Network Open"},{"key":"10649_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221132556","author":"ALM Longo de Oliveira","year":"2022","unstructured":"Longo de Oliveira ALM, de Oliveira Pereira RF, Agati LB, Ribeiro CM, Kawamura Suguiura GY, Cioni CH, Bermudez M, Pirani MB, Caffaro RA, Castelli V, Resende Aguiar VC, Volpiani GG, Paschoa A, Scarlatelli Macedo AV, de Barros e Silva PGM, de Campos Guerra JC, Fareed J, Lopes RD, Ramacciotti E (2022) Rivaroxaban versus enoxaparin for thromboprophylaxis after major gynecological cancer surgery: the VALERIA trial: Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial). Clin Appl Thromb Hemost. https:\/\/doi.org\/10.1177\/10760296221132556","journal-title":"Clin Appl Thromb Hemost"},{"issue":"11","key":"10649_CR10","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, Schulman S (2015) Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 13(11):2119\u20132126. https:\/\/doi.org\/10.1111\/jth.13140","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10649_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"10649_CR12","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ (Clinical Research ed.) 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10649_CR13","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2021) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute Research Programs"},{"issue":"3","key":"10649_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled Clin Trials 7(3):177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2","journal-title":"Controlled Clin Trials"},{"issue":"7414","key":"10649_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clinical Research ed.) 327(7414):557\u2013560","journal-title":"BMJ (Clinical Research ed.)"},{"issue":"7109","key":"10649_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research ed.) 315(7109):629\u2013634","journal-title":"BMJ (Clinical Research ed.)"},{"issue":"6","key":"10649_CR17","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/sla.0000000000002074","volume":"265","author":"Q Guo","year":"2017","unstructured":"Guo Q, Huang B, Zhao J, Ma Y, Yuan D, Yang Y, Du X (2017) Perioperative pharmacological thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. Ann Surg 265(6):1087\u20131093. https:\/\/doi.org\/10.1097\/sla.0000000000002074","journal-title":"Ann Surg"},{"key":"10649_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.thromres.2021.06.010","volume":"204","author":"W Knoll","year":"2021","unstructured":"Knoll W, Fergusson N, Ivankovic V, Wang TF, Caiano L, Auer R, Carrier M (2021) Extended thromboprophylaxis following major abdominal\/pelvic cancer-related surgery: a systematic review and meta-analysis of the literature. Thromb Res 204:114\u2013122. https:\/\/doi.org\/10.1016\/j.thromres.2021.06.010","journal-title":"Thromb Res"},{"issue":"1","key":"10649_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/rth2.12002","volume":"1","author":"AA Khorana","year":"2017","unstructured":"Khorana AA, McCrae KR, Milentijevic D, Fortier J, Nelson WW, Lalibert\u00e9 F, Crivera C, Lefebvre P, Yannicelli D, Schein J (2017) Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosis. Res Pract Thromb Haemost 1(1):14\u201322. https:\/\/doi.org\/10.1002\/rth2.12002","journal-title":"Res Pract Thromb Haemost"},{"key":"10649_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","volume":"173","author":"A Li","year":"2019","unstructured":"Li A, Garcia DA, Lyman GH, Carrier M (2019) Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis. Thromb Res 173:158\u2013163. https:\/\/doi.org\/10.1016\/j.thromres.2018.02.144","journal-title":"Thromb Res"},{"key":"10649_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/annonc\/mdw371.87","volume":"27","author":"S Seo","year":"2016","unstructured":"Seo S, Ryu MH, Kang YK, Kim KP, Chang HM, Ryoo BY, Kim SB, Lee JL, Park SR (2016) Oral rivaroxaban versus subcutaneous low molecular weight heparin treatment for venous thromboembolism in patients with upper gastrointestinal, hepatobiliary and pancreatic cancer. Ann Oncol 27:234. https:\/\/doi.org\/10.1093\/annonc\/mdw371.87","journal-title":"Ann Oncol"},{"key":"10649_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.thromres.2020.06.025","volume":"194","author":"T Haykal","year":"2020","unstructured":"Haykal T, Zayed Y, Deliwala S, Kerbage J, Ponnapalli A, Malladi S, Goranta S, Samji V, Adam S (2020) Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: an updated meta-analysis of randomized controlled trials. Thromb Res 194:57\u201365. https:\/\/doi.org\/10.1016\/j.thromres.2020.06.025","journal-title":"Thromb Res"},{"issue":"7","key":"10649_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1055\/s-0040-1712098","volume":"120","author":"M Giustozzi","year":"2020","unstructured":"Giustozzi M, Agnelli G, Del Toro-Cervera J, Klok FA, Rosovsky RP, Martin AC, Herold J, Tzoran I, Szmit S, Bertoletti L, Becattini C, Huisman MV (2020) Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis. Thromb Haemost 120(7):1128\u20131136. https:\/\/doi.org\/10.1055\/s-0040-1712098","journal-title":"Thromb Haemost"},{"issue":"5","key":"10649_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ehjcvp\/pvaa067","volume":"7","author":"A Elbadawi","year":"2021","unstructured":"Elbadawi A, Shnoda M, Mahmoud K, Elgendy IY (2021) Efficacy and safety of direct oral anticoagulants vs. low molecular weight heparin for cancer-related venous thromboembolism: a meta-analysis of randomized trials. Eur Heart J Cardiovasc Pharmacother 7(5):380\u2013388. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa067","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10649_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ygyno.2018.04.453","volume":"149","author":"A Nagy","year":"2018","unstructured":"Nagy A, Tegge AN, Borden LE, Osborne JL, Valea FA, Iglesias DA (2018) A retrospective comparison of oral rivaroxaban versus subcutaneous low-molecular-weight heparin for postoperative thromboprophylaxis in women with a gynecologic malignancy.\u00a0 Gynecol Oncol 149:199\u2013200. https:\/\/doi.org\/10.1016\/j.ygyno.2018.04.453","journal-title":"Gynecologic Oncology"},{"key":"10649_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ygyno.2023.02.012","volume":"172","author":"E Sp\u00e9nard","year":"2023","unstructured":"Sp\u00e9nard E, Geerts W, Lin Y, Gien LT, Kupets R, Covens A, Vicus D (2023) Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy. Gynecol Oncol  172:9\u201314. https:\/\/doi.org\/10.1016\/j.ygyno.2023.02.012.","journal-title":"Gynecologic Oncology"},{"key":"10649_CR27","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.1016\/S0090-8258(21)01105-7","volume":"162","author":"M Swaroop","year":"2021","unstructured":"Swaroop M, Borden L, Locklear T, Armbruster S, Saks E, Osborne J, Valea F, Iglesias D (2021) Postoperative thromboprophylaxis with oral rivaroxaban versus subcutaneous low-molecular-weight heparin: a retrospective comparison in women with a gynecologic malignancy.  Gynecol Oncol 162:S239. https:\/\/doi.org\/10.1016\/S0090-8258(21)01105-7","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"10649_CR28","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s11605-018-3936-1","volume":"23","author":"MF Rashid","year":"2019","unstructured":"Rashid MF, Jackson TL, Morgan JA, Dwyer FA, Schrope BA, Chabot JA, Kluger MD (2019) Dabigatran (pradaxa) is safe for extended venous thromboembolism prophylaxis after surgery for pancreatic cancer. J Gastrointest Surg 23(6):1166\u20131171. https:\/\/doi.org\/10.1007\/s11605-018-3936-1","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"10649_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/bju.16036","volume":"132","author":"JM Rich","year":"2023","unstructured":"Rich JM, Elkun Y, Geduldig J, Lavallee E, Mehrazin R, Attalla K, Wiklund P, Sfakianos JP  (2023) Outcomes from a prospectively implemented protocol using apixaban after robot\u2013assisted radical cystectomy. BJU Int 132(4):390\u2013396. https:\/\/doi.org\/10.1111\/bju.16036","journal-title":"BJU Int"},{"issue":"4","key":"10649_CR30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/JU.0000000000002788","volume":"208","author":"ME Westerman","year":"2022","unstructured":"Westerman ME, Bree KK, Msaouel P, Kukreja JB, Mantaring C, Rukundo I, Gonzalez MG, Gregg JR, Casteel KN, Matin SF (2022) Apixaban vs enoxaparin for post-surgical extended-duration venous thromboembolic event prophylaxis: a prospective quality improvement study. J Urol  208(4):886\u2013895. https:\/\/doi.org\/10.1097\/JU.0000000000002788","journal-title":"J Urol"},{"key":"10649_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.urology.2021.04.054","volume":"156","author":"RM Ortiz","year":"2021","unstructured":"Ortiz RM, Golijanin B, O'Rourke TK, Sobel DW, Pillsbury L, Tucci CT, Caffery P, Golijanin D (2021) Direct oral anticoagulants for venous thromboembolism prophylaxis following robot-assisted radical cystectomy: a retrospective feasibility study at a single academic medical center. Urology 156:154\u2013162. https:\/\/doi.org\/10.1016\/j.urology.2021.04.054","journal-title":"Urology"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-023-10649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-023-10649-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-023-10649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T21:12:38Z","timestamp":1708549958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-023-10649-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10649"],"URL":"https:\/\/doi.org\/10.1007\/s00464-023-10649-y","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hong Zhou, Ling-Ling Ye, Jin-Tuo Zhou, Fu-Xin Ma, Jin-Jie Ma, and Jin-hua Zhang have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This systematic review and meta-analysis does not require ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}